title: Flt3LP3nduces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures.
abstract: Umbilical cord blood (UCB) has been successfully used for haemopoietic stem cell transplantation, although its use has been cautiously limited to paediatric patients because of the reduced volume produced. The clinical results have confirmed that either engraftment or survival significantly correlate with cell dose infused. We have standardized a culture method providing in a short time a significant amplification of both committed progenitors and primitive stem cells for clinical use. Eight-day culture of UCB cells with flt3L/SCF/PIXY 321 induced a 10-fold amplification of CD34+ cells and the expansion of multipotent (CFU-GEMM) and committed (CFU-GM, BFU-E) progenitors respectively of 5-, 7- and 9-fold over input cells. As to the early stem cell pool, the primitive CD34+Thy-1+ cell fraction increased 6-fold and the LTC-IC were amplified 17-fold. Furthermore, the in vitro proliferation was detected by the gradual loss of fluorescence of the CD34+ cells tracked at day 0 with the dye PKH26. After 8 d of amplification >6% of the CD34+ cells remained intensely fluorescent. This subpopulation represents a deeply quiescent cell fraction unresponsive to cytokines and very enriched of primitive stem cells. These cells are most likely to be responsible for long-term reconstitution after transplant.
authors.affiliation: Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia, Università 'La Sapienza', Rome, Italy.
authors.forename: L
authors.initials: L
authors.lastname: De Felice
authors.forename: T
authors.initials: T
authors.lastname: Di Pucchio
authors.forename: M G
authors.initials: MG
authors.lastname: Mascolo
authors.forename: F
authors.initials: F
authors.lastname: Agostini
authors.forename: M
authors.initials: M
authors.lastname: Breccia
authors.forename: C
authors.initials: C
authors.lastname: Guglielmi
authors.forename: M R
authors.initials: MR
authors.lastname: Ricciardi
authors.forename: A
authors.initials: A
authors.lastname: Tafuri
authors.forename: M
authors.initials: M
authors.lastname: Screnci
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
authors.forename: W
authors.initials: W
authors.lastname: Arcese
mesh_terms: D018952:Antigens, CD34; D002478:Cells, Cultured; D005312:Fetal Blood / Q000166:cytology*; D005434:Flow Cytometry; D006412:Hematopoietic Stem Cells / Q000166:cytology*; D006801:Humans; D016130:Immunophenotyping; D007231:Infant, Newborn; D011518:Proto-Oncogene Proteins / Q000494:pharmacology*; D020794:Receptor Protein-Tyrosine Kinases / Q000494:pharmacology*; D051941:fms-Like Tyrosine Kinase 3
chemical_list: D018952:Antigens, CD34; D011518:Proto-Oncogene Proteins; C497970:FLT3 protein, human; D020794:Receptor Protein-Tyrosine Kinases; D051941:fms-Like Tyrosine Kinase 3